REQUEST A DEMO
Total
USD $0.00
Search more companies

Burgas Pharma EOOD (Бургас Фарма ЕООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Burgas Pharma EOOD Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Burgas Pharma EOOD (Бургас Фарма ЕООД) is based in Bulgaria, with the head office in Sofia. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on September 11, 2026. It currently has a total number of 17 (2024) employees. A growth of 6.1% was recorded in its total assets.

Headquarters
Bul. Balgariya 118, Biznes Tsentar Abakus, ET. 2
Sofia; Sofia - city;

Contact Details: Purchase the Burgas Pharma EOOD (Бургас Фарма ЕООД) report to view the information.

Basic Information
Total Employees:
Purchase the Burgas Pharma EOOD (Бургас Фарма ЕООД) report to view the information.
Registered Capital:
Purchase the Burgas Pharma EOOD (Бургас Фарма ЕООД) report to view the information.
Financial Auditors:
Purchase the Burgas Pharma EOOD (Бургас Фарма ЕООД) report to view the information.
Incorporation Date:
September 11, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Burgas Pharma EOOD (Бургас Фарма ЕООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
-66.27%
Total Assets
6.1%
Total Equity
17.24%
Return on Equity (ROE)
-36.41%
Quick Ratio
0.07%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?